Strata Critical Medical (SRTA) Intangibles (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Intangibles data on file, last reported at $46.3 million in Q1 2026.

• Quarterly Intangibles rose 242.34% year-over-year to $46.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 242.34% YoY) and the FY2025 annual result came in at $47.5 million, up 496.46% from the prior year.
• Intangibles eased to $46.3 million in Q1 2026 per SRTA's latest filing, from $47.5 million in the prior quarter.
• Across five years, Intangibles topped out at $49.8 million in Q3 2025 and bottomed at $8.0 million in Q4 2024.
• The 5-year median for Intangibles is $23.7 million (2022), against an average of $30.5 million.
• The widest annual swing landed in 2022, when Intangibles surged 1467.4%; it then plunged 68.81% in 2024.
• Tracing SRTA's Intangibles over 5 years: stood at $46.4 million in 2022, then plunged by 55.74% to $20.5 million in 2023, then plunged by 61.19% to $8.0 million in 2024, then jumped by 496.46% to $47.5 million in 2025, then declined by 2.51% to $46.3 million in 2026.
• Per Business Quant, the three latest SRTA Intangibles figures stand at $46.3 million (Q1 2026), $47.5 million (Q4 2025), and $49.8 million (Q3 2025).

Peer Comparison